Motley Fool Asset Management LLC bought a new position in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) during the fourth quarter, Holdings Channel reports. The fund bought 107,589 shares of the biotechnology company’s stock, valued at approximately $1,962,000. A number of other hedge funds and other institutional investors have also recently modified their holdings of [...]